Vernalis Plc Ord 1P is listed on the London Stock Exchange trading with ticker code VER.L, and is part of the Medicine and Biotech Research sector. It has a market capitalisation of £9,608m, with approximately 526m shares in issue. Over the last year, Vernalis Plc share price has been traded in a range of 30, hitting a high of 46.00, and a low of 16.00.
Vernalis Plc, officially known as Vernalis Plc Ord 1P was formed in October of 1988, making the company twenty nine years old. The company filed its latest accounts on 31st December 2013, showing a turnover of approximately 14.08 million GBX with gross profits of 11.84 million, or 0.0225 per issued share, and a pre-tax profit margin of -44.55%. Vernalis Plc currently has 6 directors, and has had 37 previous directors over the last 29 years. In the last set of accounts produced by Pricewaterhousecoopers Llp, the company showed 8.72 million paid in salaries to the 89 staff (average wage of 98 thousand), with the directors receiving an average 229 thousand each. In the accounts filed in 2013, the company paid 0 in dividends. These accounts also showed Vernalis Plc to have a net worth of 75.95 million, with 28.32 million held in cash.
Vernalis Plc is in the Medicine and Biotech Research sector.
|Btg Plc (BTG.L)|
|Dechra Pharmaceuticals Plc (DPH.L)|
|London Security Plc (LSC.L)|
|Gvc Holdings Plc (GVC.L)|
|Johnson Service Group (JSG.L)|
|Shares in Issue||526m|
|52 Week High||46.00|
|52 Week Low||16.00|